YSM Students Advance COVID-19 Vaccination Efforts with Innovative Community-academic Partnerships and Advocacy
Yale School of Medicine students, in collaboration with a diverse set of other students and community members, are playing a significant role in the vaccination campaign in New Haven, in Connecticut, and nationally.
Keeping Yale's COVID-19 Treatment Guidelines Up to Date
For the past year, experts across various disciplines have studied and carefully considered each new piece of evidence about treatment strategies for COVID-19 and translated it into standardized guidelines for Yale School of Medicine and Yale New Haven Health System clinicians
Waterbury Black church leaders, Yale team up to dispel myths about COVID vaccine for communities of color, seniors
In Waterbury, an aggressive effort to take the COVID-19 vaccine to hard-to-reach communities embarked on another chapter Friday. This time, one of the city’s most popular Black churches engaged in something unique to shatter some vaccine myths.Source: WTNH
Strategies to accelerate diagnosis and treatment of rare cardiovascular diseases
The current landscape for patients with rare cardiovascular disease has shifted. Using genome sequencing Yale physician-scientists have begun to elucidate the pathophysiology of genetic disorders and develop treatment guidelines and recommendations.
Yale Scientists Repair Injured Spinal Cord Using Patients’ Own Stem Cells
For more than half of the patients, substantial improvements in key functions — such as ability to walk, or to use their hands — were observed within weeks of stem cell injection, the researchers report. No substantial side effects were reported.Source: Yale News
Yale Neurologists Identify Consistent Neuroinflammatory Response in ICH Patients
According to a recent study published in "Science Immunology," A team of researchers from Yale and MIT partnernered with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients suffering from intracerebral hemorrhage.
Yale-led Clinical Trial Offers Hope for COVID Patients and a Path Forward for Research
A new randomized study could reduce the morbidity and mortality associated with COVID-19 and streamline clinical research at Yale. The study will enroll 466 patients across five different Yale New Haven Hospital sites to identify a potential COVID-19 treatment.
Covid UK Variant: What You Need To Know
Last week, Gov. Lamont announced that the first two COVID-19 cases with the “UK variant” were detected in Connecticut. This virus variant was first detected in England and seems to spread more easily between people. Its detection in our community raises alarms, but there is also a lot of misinformation circulating.Source: New Haven Independent
WHRY Funds Study on How CBD Affects the Brain
Women’s Health Research at Yale announced funding to investigate how the presumably non-intoxicating cannabis ingredient cannabidiol (CBD) affects the brain, and if it affects women and men differently. CBD use is growing in popularity exponentially, yet the safety and effectiveness of this non-regulated category of products are unknown.
Yale Researchers Find First Cases of New UK Coronavirus Variant in Connecticut
The variant cases were rapidly identified through a strong collaborative network at Yale to increase surveillance for the B.1.1.7 variant. The nasal swabs were tested by the Yale Pathology Lab and sequenced by the Yale School of Public Health.Source: YaleNews
National Women’s Hockey League Partners with Yale on COVID-19 Testing
The PCR viral RNA testing method — known as SalivaDirect — was developed by researchers at the Yale School of Public Health (YSPH). It was granted an emergency use authorization by the U.S. Food and Drug Administration after researchers performed clinical validation in collaboration with YSPH, Yale New Haven Hospital, and Yale Pathology Labs (YPL).Source: YaleNews
Vaccine Distribution in Burdened Communities Begins with Building Trust
While Black, Latinx, and Indigenous Americans are dying from COVID-19 at nearly three times the rate of white Americans, Dr. Marcella Nunez-Smith, an associate professor of internal medicine, public health, and management at Yale, worries that many people in these communities will be reluctant to receive the vaccines.Source: YaleNews
Yale Study Leads to FDA Approval of Drug to Treat Non-small Cell Lung Cancer
Based on results of a clinical trial led by Yale Cancer Center researchers, the U.S. Food and Drug Administration has approved osimertinib for the treatment of adults with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations, which occurs in about 10 percent of patients.
Black, Hispanic Children Bear Disproportionate Burden of COVID-19
Scientists from Yale and other pediatric centers found that three out of four children hospitalized with severe cases of COVID-19 were Black or Hispanic (23.3% Black and 51% Hispanic). In comparison, only 38% of adults aged 65 or over who were hospitalized were from a minority group (27% Black and 11% Hispanic), according to U.S. COVID data.Source: YaleNews